Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

Author:

Llibre JM1ORCID,Montoliu A2,Miró JM3,Domingo P4,Riera M5,Tiraboschi J6ORCID,Curran A7,Homar F8,Ambrosioni J3,Abdulghani N9,Force L10,Peraire J11,Casabona J2,Vilaró Joaquim,Masabeu Angels,Orti Amat J.,Dalmau David,Reyes Juliana,Bruguera Andreu,Montoliu Alexandra,Muntada Esteve,Podzamczer D.,Navarro G.,Cortés C.,Falcó V.,Mallolas J.,Manzardo C.,Imaz A.,Burgos J.,Gracia Mateo M.,Gutierrez M. M.,Murillas J.,Segura F.,García‐Gasalla M.,Puig T.,Vidal F.,Leon E.,Jaen À.,Almuedo A.,De Lazzari E.,Giralt D.,Martin M.,Gargoulas F.,Vanrell T.,Rubia J. C.,Vilà J.,Ferrés M.,Morell B.,Tamayo M.,Laguno M.,Martínez M.,Blanco J. L.,Garcia‐Alcaide F.,Martínez E.,Jou A.,Clotet B.,Saumoy M.,Silva A.,Prieto P.,Navarro J.,Ribera Esteve,Gurgui M.,Ribas M. A.,Campins A. A.,Fanjul F. J.,Leyes M.,Peñaranda M.,Martin L.,Vilchez H.,Calzado S.,Cervantes M.,Amengual J.,Navarro M.,Payeras T.,Cifuentes C.,Comella T.,Vargas M.,Viladés C.,Barrufet P.,Chivite I.,Chamarro E.,Escrig C.,Cairó M.,Martinez‐Lacasa X.,Font R.,Deig E.,Meyer S.,Hernandez J.,

Affiliation:

1. Infectious Diseases and “Fight AIDS” Foundation University Hospital Germans Trias i Pujol Badalona Spain

2. Statistics and Epidemiology Centre d'Estudis Epidemiològics sobre les ITS i la Sida de Catalunya (CEEISCAT, CIBERESP) Badalona Spain

3. Hospital Clínic‐ IDIBAPS University of Barcelona Barcelona Spain

4. Infectious Diseases Hospital de la Santa Creu i Sant Pau Barcelona Spain

5. Hospital Son Espases Palma de Mallorca Spain

6. Infectious Diseases Hospital Universitari de Bellvitge‐IDIBELL L'Hospitalet de Llobregat, Barcelona Spain

7. Infectious Diseases Hospital Universitari Vall d'Hebron Barcelona Spain

8. Hospital Son Llàtzer Palma de Mallorca Spain

9. Hospital de Santa Maria Lleida Spain

10. Internal Medicine Hospital de Mataró‐Consorci Sanitari del Maresme Mataró Spain

11. Internal Medicine Hospital Joan XXIII Tarragona Spain

Funder

ViiV Healthcare

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference43 articles.

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Department of Health and Human Services. Available athttp://www.aidsinfo.nih.gov/ContentFiles/Adult(accessed 24 October 2018).

2. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

3. European AIDS Clinical Society.European guidelines for clinical management and treatment of HIV‐1‐infected adults in Europe version 9.0. Available athttp://www.eacsociety.org/files/guidelines_9.0-english.pdf(accessed on 01 April 2018).

4. Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017)

5. Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3